NOTE: This activity is available only as part of a paid subscription series; it is not available for purchase as a single, stand-alone activity. The goal of this program is to improve diagnosis and surveillance of cancer using biomarker analysis and management of lung cancer using interventional pulmonology. After hearing and assimilating this program, the clinician will be better able to: 1. Describe the potential utility of blood-based biomarkers across the continuum of clinical cancer care. 2. Summarize the potential utility of and challenges associated with use of circulating tumor DNA for cancer surveillance. 3. Evaluate circulating tumor DNA kinetics in response to cancer treatment. 4. Identify benefits and challenges associated with the use of interventional pulmonology techniques for diagnosis of lung cancer. 5. Refer patients who may benefit from interventional pulmonology techniques based on patient history and lesion location.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Oncology
- Start Date: 2024-01-02 06:00:00
- End Date: 2024-01-02 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 2.0 hours
- MOC Credit Details: ABIM - 2.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology